Slide 1Management of NSCLC in Asia Tony Mok MD Professor Dept. of Clinical Oncology] The Chinese University of Hong Kong Slide 2 Asia Perspectives in NSCLC Asian perspective…

Slide 1Moderator: Dr A. Saraya Presenter: Ujjwal Slide 2 EPIDEMIOLOGY 13 th most common cancer and 8 th most common cause of cancer related deaths Pancreatic cancer is the…

Slide 1Tubulin Inhibition in Breast Cancer: A Therapeutic Target Critical to Improving Outcomes William J. Gradishar, MD Professor of Medicine Robert H. Lurie Comprehensive…

1.Functional genomics and cancer subtyping with a human cancer coessentiality network Traver Hart Laboratory of Jason Moffat Donnelly Centre, U. Toronto NetBio SIG, 11 July…

1.High-throughput microRNA functional screening using the Acumen eX3 to identify repressors of a tumorigenic signal transduction pathwayNeil Kubica, Janie Zhang, Greg Hoffman…

1.Characterization of a New Fusion Gene in Acute Myeloid Leukemia Jocelyn Reader Ph.D. Candidate in Human Genetics University of Maryland Baltimore Advisor: Dr. Yi Ning Feb.…

1.Plasma 25-Hydroxyvitamin D Concentration, VDR polymorphisms and their Interaction are Associated with Survival in Colorectal Cancer Patients LINA ZGAGA Associate Professor…

1. Monoclonal antibodies Anticancer therapy Weihua Wu 2. What is antibodies An antibody is a protein used by the immune system to identify and neutralize foreign objects…

1. Stem Cells in Cancer:A Review Jovana J. Grbi ć Schultz Group Seminar October 18, 2005 2. Stem Cells in Cancer:A Review Introduction and Background What is a stem cell?What…

1. Clinical Activity of the Oral ALK Inhibitor,Clinical Activity of the Oral ALK Inhibitor, Crizotinib (PF-02341066), in Patients withCrizotinib (PF-02341066), in Patients…